Rare diseases
Investigational molecules
Locations
Rumpiskes G. 4, Klaipedos M. Sav., 91131 Klaipeda, Lithuania
Kardiologijos ir reabilitacijos klinika UAB in Klaipeda, Lithuania specialises in clinical trials of conditions such as Arteriosclerosis, Atrial fibrillation, Cerebrovascular accident prophylaxis, Dyslipidaemia, and other specialisations. This site conducts important research.
The Kardiologijos ir reabilitacijos klinika UAB conducts studies aimed at preventing and treating cardiovascular disease. Trials address patients at high risk of events, explore new therapies to lower the incidence of major adverse cardiovascular events, and evaluate interventions for heart failure with reduced ejection fraction.
With two investigators overseeing six active trials, the site is advancing innovative treatments that could improve outcomes for patients with heart conditions and high‑risk profiles.
Research at the clinic also targets nutritional and metabolic diseases, focusing on disorders that increase cardiovascular risk. Studies evaluate novel agents designed to lower triglyceride levels and enhance lipid‑lowering strategies in individuals with severe hypertriglyceridemia.
The multidisciplinary team leverages its expertise to test therapies that may reduce metabolic risk factors and support overall heart health.
Clinical trials currently enrolling participants at this site.
LithuaniaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
LithuaniaStudy of ISIS 678354 for Patients with Severe High Triglycerides
LithuaniaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
LithuaniaStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
LithuaniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
LithuaniaStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction
LithuaniaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
LithuaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
